NLRP3 and COVID-19: If this is the case, then proposed COVID-19 treatments, like Quercetin, an Nlrp3 inflammasome inhibitor, could treat acute COVID-19 infections by inhibiting the cytokine storm and, ultimately, prevent the formation of malignant processes [13].